Last reviewed · How we verify
Fludarabine Phosphate for Injection — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Fludarabine Phosphate for Injection (Fludarabine Phosphate for Injection) — Chinese PLA General Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Fludarabine Phosphate for Injection TARGET | Fludarabine Phosphate for Injection | Chinese PLA General Hospital | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Fludarabine Phosphate for Injection CI watch — RSS
- Fludarabine Phosphate for Injection CI watch — Atom
- Fludarabine Phosphate for Injection CI watch — JSON
- Fludarabine Phosphate for Injection alone — RSS
Cite this brief
Drug Landscape (2026). Fludarabine Phosphate for Injection — Competitive Intelligence Brief. https://druglandscape.com/ci/fludarabine-phosphate-for-injection. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab